China SXT Pharmaceuticals, Inc. Quarterly Contract with Customer, Liability, Current in USD from Q1 2023 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary
China SXT Pharmaceuticals, Inc. quarterly Contract with Customer, Liability, Current history and growth rate from Q1 2023 to Q1 2024.
  • China SXT Pharmaceuticals, Inc. Contract with Customer, Liability, Current for the quarter ending March 31, 2024 was $188K, a 13.4% increase year-over-year.
Contract with Customer, Liability, Current, Quarterly (USD)
Contract with Customer, Liability, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $188K +$22.1K +13.4% Mar 31, 2024 20-F 2024-08-13
Q1 2023 $166K Mar 31, 2023 20-F 2024-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.